Announcement
James T. Joins Mavengity as a Medical Writer
With James now writing full time for our Healthcare & Medical desk, Mavengity has formally expanded into dedicated medical authorship.
Read the Article
Posted in the last 24 hours
Fresh from the desks
Medicaid Policy
Why People Who Still Qualify Keep Losing Their Medicaid
New Medicaid work requirements and twice-yearly eligibility checks take effect in 2027. The central danger isn't that ineligible people will be removed, it's that eligible people will lose coverage simply because they can't get through the paperwork, and research shows that's cheap to prevent.
Clinical Trials
The Trouble With "Targeted" Radiation: It Still Hits the Kidneys on the Way to the Tumor
Radiopharmaceuticals were pitched as precision radiation that spares healthy tissue. As more of them reach clinical trials, developers are finding the isotopes damage kidneys, livers, and bone marrow on the way to the tumor, a structural tradeoff rather than a fixable glitch.
Science Policy
Why China Is Reining In the Very Clinical-Trial System the U.S. Wants to Copy
American researchers want to copy the fast, lightly reviewed investigator-initiated trials that helped China pull ahead in biotech. China is now tightening that same system after safety and transparency problems, including a patient death. The timing is the whole story.
Pharma Supply Chain
When a Life-Sustaining Drug Depends on a Single Factory
Sanofi is running short of two enzyme-replacement drugs that Pompe disease patients depend on to stay stable, tracing to a quality bottleneck at a single Irish plant. The shortage exposes a structural fragility built into how rare-disease medicines are made, not a failing unique to one company.
Retirement
Retiring Because the Market Is High Is a Bet, Not a Plan
With stocks strong, the advice arrives on cue, this is a great time to retire. But retirement is close to a one-way door, and anchoring an irreversible decision to a fleeting market condition is backwards. The real question is whether your plan is robust enough that the market's level stops mattering.
Real Estate
Why Your Condo Dues Are Rising, and Why the Cost Was Always There
The median condo fee is up 29% since 2019, and special assessments are hitting some owners for over $100,000. The rising dues are not a new cost. They're a decades-old cost, deferred through underfunded reserves, finally coming due after the Surfside collapse forced a reckoning.
Aerospace & Defense
Why the FAA Is Inspecting Hundreds of Boeing Jets That Have No Cracks
The FAA ordered inspections of roughly 471 U.S. 737 MAX jets for a structural crack that has not been found on a single one of them. Read closely, the order is not evidence of another Boeing failure, it's damage-tolerance engineering doing exactly what it's designed to do.
Compliance
Why Small Businesses Can't Find the Federal Cybersecurity Help That Already Exists
A new bipartisan Senate bill doesn't create any new cybersecurity tools for small businesses. It just orders a report on the federal help that already exists. The remedy it chose reveals that the real failure is awareness, not resources, a problem that recurs across nearly everything government tries to do.
Biotech Workforce
Boston Mastered Biotech's First Era. One Founder's Move to California Is a Question About Its Second
A Harvard-and-MIT-trained founder who fits Boston's exact entrepreneurial profile built his biotech company in California instead. One anecdote isn't a migration, but it points at a real risk, the source of biotech's regional advantage may be shifting from wet-lab biology to computation.
Announcements
News from Mavengity
Browse by topic
Where would you like to start?
Every article on Mavengity is written by a dedicated topic desk and checked against current market practice.
Insurance
Home, auto, life, and health coverage, explained clearly and checked against the fine print.
Browse InsuranceMortgage
Rates, refinancing, and first-time buyer strategy, without the jargon lenders assume you already know.
Browse MortgagePersonal Finance
Budgeting, saving, and everyday money habits that compound. No get-rich-quick promises.
Browse Personal FinanceLegal
Contracts, consumer rights, and disputes, explained so you know where you stand.
Browse LegalHealthcare & Medical
Health coverage and medical billing, broken down so surprise bills are less likely to surprise you.
Browse Healthcare
Why Mavengity
Editorial standards you can check
Independently researched
We start from public rate filings, regulator guidance, and lender disclosures, not marketing copy.
Plain-English explanations
If a term needs a footnote, we explain it in the sentence instead of hiding it in the fine print.
Straight, not slanted
We flag trade-offs and blind spots, not just the upside, so you get the full picture before you decide.
Written for readers, not lenders
Mavengity is reader-supported and editorially independent from the products we cover.